The prognostic role of metabolic tumor burden in 18F-FDG PET/CT in the primary staging of rectal cancers

ConclusionThis research suggests that whole-body tumor burden assessed through staging FDG PET/CT can serve as an independent imaging biomarker for prognostication in rectal cancer patients.

http://link.springer.com/10.1007/s40336-024-00621-8

Source: Clinical and Translational Imaging - March 4, 2024 Category: Radiology Source Type: research